MICHAEL FARNSWORTH: Open Payments
NPI 1932183274 · MANKATO, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$90,108 in 90 payments from 3 companies in 2025. Trend: 2023 $66,106 · 2024 $156,948 · 2025 $90,108
Speaker / faculty: $71,804Consulting: $10,753Travel & lodging: $6,338Food & beverage: $1,214
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 46 | $41,437 |
| Neurocrine BioSciences, Inc. | 24 | $32,984 |
| E.R. Squibb & Sons, L.L.C. | 20 | $15,686 |
Products named: INGREZZA, ABILIFY MAINTENA, REXULTI, COBENFY, ABILIFY ASIMTUFII.
Industry payments across MN — which companies pay providers there.
